Other
orciprenaline
Safety score · 0–100
Caution
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
Orciprenaline is a cosmetic ingredient used in product formulations. Exercise caution due to limited available safety data.
Orciprenaline (metaproterenol) is a non-selective beta-adrenergic agonist used as a bronchodilator for asthma and COPD, with pharmacological activity similar to isoprenaline. It carries risks of cardiovascular side effects including tachycardia. As a prescription pharmaceutical substance with no cosmetic regulatory history, it is excluded from EU cosmetics regulation scope. No REACH registration or SCCS evaluation exists for cosmetic applications.
Known concerns
- Beta-adrenergic bronchodilator drug incompatible with cosmetics
- Cardiovascular side effects including tachycardia
- No EU cosmetics authorization or SCCS evaluation
- Outside scope of cosmetics regulation
References
EU CosIng database
European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.
Related others
Check your shelf
Find orciprenaline in your products.
Scan any cosmetic product with LuxSense to see if it contains orciprenaline and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.